← Back to Search

Supportive Text Messaging for Mental Health Wellness (Text4Support Trial)

N/A
Recruiting
Research Sponsored by Vincent Agyapong
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 weeks, 3, 6 and 12 months.
Awards & highlights

Text4Support Trial Summary

This trial will test whether a text messaging service can help improve mental health outcomes, satisfaction, and health services utilization for people accessing different degrees of psychiatric care.

Who is the study for?
This trial is for new or recently discharged patients from psychiatric care in Nova Scotia who own a mobile device, can read English text messages, and are willing to provide consent. It's not suitable for those unable to read texts in English or without a capable mobile phone.Check my eligibility
What is being tested?
The study tests if supportive daily text messages based on cognitive-behavioural therapy can improve mental health outcomes compared to usual care alone. Participants will be randomly assigned to receive either the text message program plus usual care or just the usual care.See study design
What are the potential side effects?
Since this intervention involves receiving supportive text messages, there are no direct physical side effects. However, participants may experience emotional discomfort if sensitive topics are touched upon in the texts.

Text4Support Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 weeks, 3, 6 and 12 months.
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 weeks, 3, 6 and 12 months. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Generalized Anxiety Disorder
Change in Major Depressive Disorder
Change in Recovery
+2 more
Secondary outcome measures
Health services utilization (Emergency Department visits)
Health services utilization (crisis calls)
Health services utilization (hospital admissions)
+4 more
Other outcome measures
Implementation (acceptability)
Implementation (appropriateness)
Implementation (cost-effectiveness)
+2 more

Text4Support Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Text4Support ArmExperimental Treatment1 Intervention
Patients in the intervention (Text4Support) arm of the study will receive the usual care (i.e. community care, follow-up appointments), plus daily automated supportive text messages from an online application.
Group II: Care as usual armActive Control1 Intervention
Patients in the control arm of the study will receive the usual care, which includes the freely accessible Health Authority approved low-intensity e-mental health services. They will receive a single text message informing and encouraging them to utilize current MHAP resources on the NS Health website. They will not receive automated daily supportive text messages.

Find a Location

Who is running the clinical trial?

Vincent AgyapongLead Sponsor
Nova Scotia Health AuthorityOTHER
258 Previous Clinical Trials
82,354 Total Patients Enrolled
10 Trials studying Depression
32,450 Patients Enrolled for Depression
Dalhousie UniversityOTHER
167 Previous Clinical Trials
401,638 Total Patients Enrolled
5 Trials studying Depression
30,548 Patients Enrolled for Depression

Media Library

Mental health supportive text messages Clinical Trial Eligibility Overview. Trial Name: NCT05411302 — N/A
Depression Research Study Groups: Text4Support Arm, Care as usual arm
Depression Clinical Trial 2023: Mental health supportive text messages Highlights & Side Effects. Trial Name: NCT05411302 — N/A
Mental health supportive text messages 2023 Treatment Timeline for Medical Study. Trial Name: NCT05411302 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What results are researchers hoping to attain through this research endeavor?

"This clinical trial's main objective, observable over intervals of Baseline, 6 weeks, 3 months, 6 months and 12 months is to assess the alteration in Major Depressive Disorder. Supplementary goals involve examining disparities between groups in health services utilization (crisis calls), patient satisfaction through a 5-point self-generated Likert scale assessment, as well as variations in length of stay following hospitalisation among cohorts."

Answered by AI

Is this investigation currently enrolling participants?

"Per clinicaltrials.gov's records, this investigation is no longer accepting patients - the trial was first posted on September 1st 2022 and last updated June 8th 2022. However, there are 1914 other medical trials currently looking for participants at present."

Answered by AI

Is there an opportunity for me to participate in this clinical experiment?

"This clinical study aims to recruit 1500 individuals between 16 and 65 years of age who present with involutional psychosis. The team overseeing this trial has established a few inclusion criteria: being an initial patient in the TMHP, DH, RASP or MHCC; having been discharged from ED or PIU within seven days prior to consenting; owning a mobile device that can receive text messages; comprehension of written English language material; and providing informed written permission."

Answered by AI

Is this research endeavor accepting seniors aged seventy-five or above?

"This clinical trial seeks participants aged between 16 and 65 years old."

Answered by AI

Who else is applying?

What site did they apply to?
Nova Scotia Health - Abbie J. Lane Memorial Building QEII Health Sciences Centre
What portion of applicants met pre-screening criteria?
Met criteria
~656 spots leftby Jul 2025